Together these findings suggest that MTOR signaling and its impact on ROS and metabolism play an important role in the pathophysiology of COVID-19, and drugs targeting several of these pathways could have synergistic effects with consequences on disease progression and severity. The gene discussed is MTOR; the disease is COVID-19.